Stock Events

Orgenesis 

$0.74
22
+$0.07+9.99% Friday 20:00

Statistics

Day High
0.85
Day Low
0.68
52W High
1.31
52W Low
0.25
Volume
486,947
Avg. Volume
198,611
Mkt Cap
25.42M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

21MayConfirmed
Q2 2022
Q3 2022
Q4 2022
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.29
-0.13
0.02
0.18
Expected EPS
0
Actual EPS
-0.29

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ORGS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Health Technology
Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
Show more...
CEO
Vered Caplan
Employees
146
Country
US
ISIN
US68619K2042
WKN
000A2H7XQ

Listings